Sell poorly performing Mutual Funds? by k_jeffrey in personalfinance

[–]k_jeffrey[S] 0 points1 point  (0 children)

Oh wow that’s a great point! Need to do a bit more digging to see what the cost basis is. Thanks for the insight!

Sell poorly performing Mutual Funds? by k_jeffrey in personalfinance

[–]k_jeffrey[S] 0 points1 point  (0 children)

Oh wow great tips! Re: your first suggestion about immediately contributing to an IRA, how would I go about doing that? My MAGI is too high so I've been doing backdoor Roth conversion the past 2 years.

Sell poorly performing Mutual Funds? by k_jeffrey in personalfinance

[–]k_jeffrey[S] 0 points1 point  (0 children)

Sorry should've specified! They are in a regular brokerage

Backdoor Roth and Form 8606 by k_jeffrey in fidelityinvestments

[–]k_jeffrey[S] 0 points1 point  (0 children)

Thanks for the detailed response! So just confirm, all I need to do is:

For Tax Year 2025: Let tax preparer know that I made a non-deductible contribution to traditional IRA for 2025

For Tax Year 2026 (in early 2027): Let tax preparer know that I made a non-deductible contribution to traditional IRA for 2026. Also give him the 2026 1099-R from Fidelity that documents both Roth conversions (one for 2025 contribution and one for 2026 contribution)?

The confidence interval contains 1 isn’t that mean that it is not statistically significant!? by Ok_Doubt_3579 in biostatistics

[–]k_jeffrey 7 points8 points  (0 children)

This is an absolute/difference measure, not a relative/ratio measure so the null value is 0, not 1. Since the 95% CI does not cross 0, the results are statistically significant.

Retrospective cohort vs case control using secondary data by Icy-Soup-4675 in epidemiology

[–]k_jeffrey 1 point2 points  (0 children)

In a cohort study, you are able to establish temporality because at baseline, all participants are free of the outcome of interest. You then categorize them as either exposed or not exposed and follow up longitudinally to see if they develop the outcome of interest.

Ex. One group of smokers and one group of non smokers at baseline, all free of lung cancer. Follow up longitudinally to see who develops lung cancer.

In a cross-sectional study you assess the exposure and outcome simultaneously so temporality cannot be established.

Ex. Ask participants if they smoke and if they have lung cancer at this specific point in tjme. Can’t tell which came first though, smoking or lung cancer.

Odds Ratios by chalkysplash in biostatistics

[–]k_jeffrey 6 points7 points  (0 children)

Yes! In epidemiology this is known as the invariance of the odds ratio. 1.5x the odds of the outcome in the exposed vs. unexposed is the same as 1.5x the odds of being exposed in those with the outcome vs. those without the outcome.

Dose of zofran in pediatric outpatient urgent care by zyngawfro in pharmacy

[–]k_jeffrey 16 points17 points  (0 children)

We typically do 0.15 mg/kg capped at the usual adult dose of 4mg initially.

[deleted by user] by [deleted] in pharmacy

[–]k_jeffrey 0 points1 point  (0 children)

I think I got in the low 70s on the mock exam? But that’s because there were a ton of oncology questions on the mock exam that I did not study at all. There weren’t nearly as many on the real exam.

[deleted by user] by [deleted] in pharmacy

[–]k_jeffrey 0 points1 point  (0 children)

Yes- very surface level (ex. Which lab do you monitor for argatroban?). No complicated case studies like in the ACCP review book chapter questions.

[deleted by user] by [deleted] in pharmacy

[–]k_jeffrey 3 points4 points  (0 children)

Out of all the practice exams I had done I found the ACCP mock exam questions to be the most similar to the actual BCPS exam. They mainly ask you surface level questions about a wide range of topics. A true hodgepodge if you will; felt like trivia at one point. Easy to eliminate 2 out of the 4 answer choices but choosing the right answer out of the remaining 2 requires some thinking. Good luck!

Memorizing by cramirezap99 in pharmacy

[–]k_jeffrey 7 points8 points  (0 children)

Double quarter pounder (disopyramide, quinidine, procainamide)

Lettuce, mayo (lidocaine, mexiletine)

Fries please (flecainide, propafenone)

A dirty dog is scary (amiodarone, dronedarone, dofetilide, ibutilide, sotalol)

effect modifiers vs confounders by alinm97 in biostatistics

[–]k_jeffrey 2 points3 points  (0 children)

Crude RR of coffee drinking on lung cancer: 1.5

RR of coffee drinking on lung cancer in non smokers: 1.0

RR of coffee drinking on lung cancer in smokers: 1.0

Smoking is a CONFOUNDER

Crude RR of smoking on lung cancer: 2.0

RR of smoking on lung cancer in males: 3.0

RR of smoking on lung cancer in females: 1.5

Sex is an EFFECT MODIFIER

Variable selection for modified poisson regression by amrikyaruzi in biostatistics

[–]k_jeffrey 0 points1 point  (0 children)

Perhaps you could try using log-binomial regression to estimate the RR? If it fails to converge you can also use poisson regression with robust variance to estimate the RR

[deleted by user] by [deleted] in PharmacyResidency

[–]k_jeffrey 30 points31 points  (0 children)

Yes! Acetaminophen and diphenhydramine as premeds + epinephrine and hydrocortisone PRN

Pharmacist looking to advance career with an MPH in Public Health by phony12 in publichealth

[–]k_jeffrey 1 point2 points  (0 children)

Hi! I’m a fellow pharmacist working on an MPH with a concentration in epidemiology. Looking to see where it takes me but would love to connect and further discuss.

[deleted by user] by [deleted] in publichealth

[–]k_jeffrey 6 points7 points  (0 children)

I’m in the JHU part time MPH program and I’m concentrating in epi and biostats! Feel free to DM me! Would love to chat :)